View this email in your browser
Share Share
Tweet Tweet
Forward Forward

Update for Primary Care

Our latest primary care news and guidance.
April 2022
COVID-19News | Clinical knowledge summaries | Into practice | Events | Get involved | Other resources


Updates to managing COVID-19 guideline

We have added new recommendations on:
We are continuously updating our COVID-19 guidelines to incorporate the latest evidence and keep abreast of new developments in diagnosing and treating COVID-19. We’ll highlight recent updates in this monthly email communication, or you can keep up to date on the latest live changes through our website.


Person measuring their waistline

Keep the size of your waist to less than half of your height

Our new draft guideline on obesity recommends people should keep their waist measurement to less than half their height. Adults with a body mass index (BMI) below 35 kg/m² (obesity class 2) are encouraged to measure their own waist-to-height ratio. Using the waist-to-height ratio, in conjunction with the BMI, can provide an estimate of the accumulation of fat around the abdomen to help assess health risks, such as type 2 diabetes, hypertension or cardiovascular disease. A consultation on the proposed recommendations is open until Wednesday 11 May 2022.

Person doing a diabetes glucose test

Real-time monitoring to benefit thousands of people with diabetes

We’ve published updated guidance on type 1 diabetes in adults and type 1 and type 2 diabetes in children and young people. More than 250,000 people are set to benefit from new technology to help them manage their type 1 diabetes and reduce the need for finger-prick testing by up to 50%. Our guidance recommends the use of real-time continuous glucose monitoring and expands the use of intermittently scanned glucose monitoring devices – also known as flash monitoring – to the whole of the type 1 patient population.

Tackling antimicrobial resistance through subscription-style payment model

Two new antimicrobial drugs - cefiderocol and ceftazidime–avibactam - could, in the next few months, be the first to be made available as part of a new innovative subscription-style payment model. The drugs will be used to treat patients with severe drug-resistant infections who would otherwise have limited or no other treatment options. The new model has been designed to try and address the lack of new antimicrobials being developed and the growing threat posed by antimicrobial resistance.

Catch up on all our latest news articles
NICE Talks logo

Interview with our chief executive, Dr Sam Roberts

In this month’s NICE Talks podcast, we chat with chief executive, Dr Sam Roberts. Sam outlines her initial thoughts on the organisation, her priorities for the next 12 months and how she plans to tackle some of the challenges we face. She reflects on how NICE will adapt to new drugs, digital technologies, devices and diagnostics and explains how she’ll build upon the solid foundations established by her predecessors.

Clinical knowledge summaries

New topics and updates include:

Our CKS provide primary care practitioners with a readily accessible summary of the evidence base and best practice guidance for over 370 topics. These cover over 1,000 clinical presentations or patient scenarios, free to access in the UK.

Into practice

Summary of antimicrobial prescribing guidance: managing common infections

Our summary of antimicrobial prescribing guidance is a rapid reference table designed to assist health professionals when managing common infections. It contains recommendations from both NICE and Public Health England. This popular document, which was previously available on our website, is now hosted on the British National Formulary site. We hope you continue to find this resource helpful in your practice.

Read summary of antimicrobial prescribing guidance


Real world evidence framework (RWE) launch

Join us for the launch event of our RWE framework on:

  • Thursday 23 June 2022, 2pm to 3pm, online.

Find out how our RWE framework will help  resolve knowledge gaps and drive forward patient access to innovative treatments by:

  • identifying where real world data can be used to reduce uncertainties and improve guidance
  • describing best practices for the planning, conduct, and reporting of real world evidence studies to improve the quality and transparency of evidence.
Register for your free ticket

Get involved

Help shape the future of NICE guidelines

We want to change the way NICE guidance appears online to make it more useful and usable.
We’ve created an early prototype for how our Type 2 diabetes in adults: management guideline could look in the future, and we’d like to know what you think of it.
Redesigning our guidance will help you find up-to-date information you need when you need it, in the right format. It will be easier to navigate, more accessible and enable you to access the underpinning evidence to support shared decision making.

View the prototype

Comment on a consultation

Our current consultations include:

Consultation is a key part of our guidance development process. It enables those with an interest in our guidance to comment at specific stages and feedback into the decision-making process.
See all our open consultations

Join a committee

We’re looking for health and social care professionals, including GPs, pharmacists and physicians with particular expertise in care of the elderly, to join our:

Our guidance and quality standards are developed by independent committees. Join us and have an active role in producing a guideline or quality standard.
See all our committee vacancies

Observe a meeting

We’re currently holding all our public meetings virtually. You'll need to register in advance to join. 

Upcoming public meeting:

  • Friday 20 May 2022 – Medical technology advisory committee
    Registration closes on Friday 13 May 2022.
    Agenda and register
Our advisory committee meetings, technology appraisal appeal hearings and public board meetings are open to the public. Holding them in public supports our commitment to having processes in place that are rigorous, open, and transparent.
See all our public meetings

Other resources

Dr Sam Roberts, NICE chief executive

Lancet interview with our chief executive

In a recent interview, our chief executive, Dr Sam Roberts, discusses how her work at NICE is informed by her clinical experience and her belief that the patient is the expert.

Read Lancet interview

unsubscribe from this list